Apnicaf Oral Solution
Marketer
Abbott
Salt Composition
Caffeine (20mg/ml)
Overview Apnicaf Oral Solution
Preterm infants experiencing apnea (a condition marked by recurrent breathing pauses) may be treated with the prescribed medication, Respiflow Oral Solution. This solution promotes regular breathing patterns and lessens instances of interrupted breathing in premature babies. Administration of Respiflow Oral Solution must be overseen by medical personnel, delivered orally or through a feeding tube. Nursing mothers treating their infants with this medication should avoid caffeine consumption, as it can transfer into breast milk. Commonly reported side effects include agitation, sleep disturbances, headaches, lightheadedness, and elevated heart rate. If these effects persist or intensify, consult your physician; management strategies may be available to mitigate these reactions.
Uses of Apnicaf Oral Solution
Respiratory pauses in premature infants
Major Benefits of Apnicaf Oral Solution:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Always consult the product label for usage instructions prior to consumption. Employ a measuring cup for accurate dosing and ingest orally. Ensure thorough shaking before each use. Apnicaf Oral Solution can be consumed with or without food; however, consistent timing is recommended for optimal results.
Common Side effects of Apnicaf Oral Solution:
- Restlessness
- Headache
- Dizziness
- Increased heart rate
- Insomnia (difficulty in sleeping)
How to use Apnicaf Oral Solution:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Always consult the product label for complete instructions prior to consumption. Use a measuring cup for accurate dosing and ingest orally. Ensure thorough shaking before each use. Apnicaf Oral Solution can be consumed with or without food; however, consistent timing is recommended for optimal results.
How Apnicaf Oral Solution works:
Apnicaf Oral Solution acts as a respiratory stimulant. Its mechanism involves inhibiting adenosine and phosphodiesterase, thereby enhancing brain and respiratory function in premature infants. This effect diminishes apnea episodes and promotes independent breathing in these newborns.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Apnicaf Oral Solution is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Apnicaf Oral Solution during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCAUTION
Administering Apnicaf Oral Solution to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended until maternal treatment concludes and the medication is fully cleared from the system.
DrivingUNSAFE
Using Apnicaf Oral Solution might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Apnicaf Oral Solution to individuals with renal impairment. Seek medical advice.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Apnicaf Oral Solution's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Apnicaf Oral Solution :
NA
Facts to Know About Apnicaf Oral Solution
| Label | Value |
|---|---|
| Chemical Type | Xanthine-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | A1 and A2 adenosine receptor blocker |
3,018 People bought this recently